Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study

Medicine and Dentistry

• Patient 100%
• Methicillin Resistant Staphylococcus Aureus 91%
• Prevalence 58%
• Staphylococcal Pneumonia 58%
• Pneumonia 41%
• Patient Population 16%
• Pathogen 16%
• Diseases 8%
• Odds Ratio 8%
• Logistic Regression Analysis 8%
• Cohort Analysis 8%
• Lower Respiratory Tract Infection 8%
• Antibiotic Resistance 8%
• Skin Infection 8%
• Staphylococcus Infection 8%
• Global Health 8%
• Disease 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Methicillin-Resistant Staphylococcus Aureus 91%
• Prevalence 58%
• Staphylococcal Pneumonia 58%
• Pneumonia 41%
• Infectious Agent 16%
• Diseases 8%
• Staphylococcal Infection 8%
• Skin Infection 8%
• Lower Respiratory Tract Infection 8%
• Antibiotic Resistance 8%

Nursing and Health Professions

• Prevalence 58%
• Pneumonia 41%
• Hospital 16%
• Adult 16%
• Culture 16%
• Diseases 8%
• Odds Ratio 8%
• Logistic Regression Analysis 8%
• Cohort Analysis 8%
• Skin Infection 8%
• Procedures 8%
• Antibiotic Resistance 8%
• Staphylococcus Infection 8%
• Lower Respiratory Tract Infection 8%